San Antonio, TX, United States of America

Qiuli Huang




Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Qiuli Huang

Introduction

Qiuli Huang is a prominent inventor based in San Antonio, TX (US), known for her significant contributions to the field of pharmaceuticals. With a total of 10 patents to her name, she has made remarkable advancements in the development of novel chemotherapeutic agents and formulations.

Latest Patents

Among her latest patents is the invention of deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3', 4′:6,7]indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione. This invention discloses two novel deuterated Karenitecin® analogs, along with their pharmaceutically-acceptable salts and derivatives. It also includes methods for synthesizing these analogs and formulations that comprise them, as well as methods of administration to subjects in need. Another significant patent focuses on compounds and methods for reducing the undesired toxicity of chemotherapeutic agents. This patent presents novel compositions that serve as toxicity-reducing agents for various chemotherapeutic agents and as treatments for specific diseases and conditions.

Career Highlights

Qiuli Huang is currently associated with Bionumerik Pharmaceuticals, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work has been instrumental in advancing the understanding and application of chemotherapeutic agents.

Collaborations

Throughout her career, Qiuli has collaborated with notable professionals in her field, including Harry Kochat and Frederick H Hausheer. These collaborations have further enhanced her research and development efforts.

Conclusion

Qiuli Huang's innovative work in the pharmaceutical sector has led to significant advancements in chemotherapeutic agents and formulations. Her contributions continue to impact the field positively, showcasing her dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…